At its November 29 meeting, the KraussMaffei Group (KMG) Supervisory Board acknowledged with approval CEO Dr. Michael Ruf's personal request not to extend his contract, which expires at the end of March 2023, and named Mr. Li Yong as his successor.

Since 2018, KraussMaffei Group GmbH has been part of KraussMaffei Company Limited, a stock corporation listed on the Shanghai Stock Exchange. Majority shareholder is Sinochem, one of the world’s leading chemical conglomerates.

Ruf will remain KMG Management Board Chairman and CEO until December 31, 2022, with his responsibilities transferred to Li on January 1. Until his contract's expiration on March 31, 2023, Ruf will continue to work to ensure a comprehensive handover and a smooth transition. He will also remain involved in some ongoing projects.

Ruf has been a member of the KMG Management Board since April 2019, initially as Chief Operating Officer and, since April 2020, as CEO for KMG and for KraussMaffei Company Limited.

Li Yong will take over as KraussMaffei Group CEO on January 1, 2023.

New CEO Li Yong has been with Sinochem for nearly two decades in a variety of executive, operational and project management positions. Having spent a third of his career abroad, he has intensive intercultural cooperation experience. He has already been involved in KraussMaffei's business since June 2022.

Bai Xinping, Supervisory Board Chairman, said, "Dr. Ruf has successfully steered KraussMaffei with a sure hand through some unprecedented challenges in recent years. He has also significantly developed the company and comprehensively modernized its processes, technology, strategy and site development. His committment to KraussMaffei's future is greatly appreciated."

"After four eventful years with KraussMaffei, now is the right time to pass the baton onto my successor," stated Ruf. "I am very proud that together with the shareholders we have succeeded in positioning KraussMaffei for a better future. I would like to thank the employees for their contribution and their representatives from the works council for their trust during the transformation."

"I am very much looking forward to my new role at KraussMaffei and to working with my new colleagues. Dr. Ruf has decisively driven KraussMaffei's transformation and set an important course for the future, for which I am very grateful," Li shared. "Together with our main shareholder Sinochem, KraussMaffei is now ready for the next step. We will expand KraussMaffei's technological lead and continue to drive forward the company's internationalization."